An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics.
Clinical trial NCT01480271 · COMPLETED
Trial details
- NCT number
- NCT01480271
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-30
- Primary completion
- 2011-09-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.